To further assess the therapeutic potential of Pa for ACH, we determined how Pa treatment affects FGFR3 downstream signaling in chondrocytes using ATDC5 cells expressing WT or ACH FGFR3. This evidence concerns the gene FGFR3 and achondroplasia.